GLP Watchdog is live at glpwatchdog.org: an independent register of U.S. GLP-1 sellers, with rated entries for 500+ companies, 180+ FDA warning letters, and per-month pricing. Every seller is scored on the same six measures, including compounded-only companies other ratings leave out.
LOS ANGELES — August 26, 2026 — GLP Watchdog, an independent consumer register of the companies selling GLP-1 weight-loss medications to Americans online, is now live at glpwatchdog.org. The site publishes a rated entry for over 500 sellers, a searchable archive of over 180 FDA warning letters issued to companies in the category, and month-by-month pricing for each seller that publishes one.
The GLP-1 market has moved online faster than the tools consumers use to evaluate it. Americans can now buy semaglutide or tirzepatide from hundreds of telehealth companies, compounding pharmacies, and med spas, many of which launched in the past two years. Which company actually dispenses the drug, what it charges once the introductory month ends, and whether federal regulators have written to it are three questions that are difficult to answer from a seller’s own website.
GLP Watchdog exists to answer those three questions in one place, for every seller, in a consistent format.
Earlier this month, U.S. News & World Report published its debut ratings for GLP-1 telehealth platforms, covering 20 companies and excluding those that sell only compounded GLP-1s. That exclusion is defensible on clinical grounds and it leaves out a large share of the market Americans are actually buying from. GLP Watchdog covers the compounded segment rather than setting it aside, and treats a seller’s compounding relationships, pharmacy accreditation, and enforcement history as scored inputs instead of a reason for omission.
“Every seller in this category tells you it is the safe one,” said Ruth Calder, enforcement editor at GLP Watchdog. “Far fewer will tell you which pharmacy fills the prescription, or whether a federal regulator has already written to the company behind the brand name. Both of those are on the public record. We put them on the page.”
How the ratings work
Each seller receives a single score from 0 to 10, built from six weighted measures: value, effectiveness, user experience, trust and safety, accessibility, and support. Value comes from the cheapest standing monthly price a seller publishes, measured against the category median. Trust and safety draws on pharmacy accreditation, prescriber oversight, and FDA enforcement history.
No editor assigns a seller a number. Each of the six inputs is a function of something the seller has published or something a regulator has published about it, which means a rating can be reproduced by a reader who follows the same sources.
What a month actually costs
Pricing is recorded per calendar month rather than as the figure on a seller’s marketing page.
“Sellers quote a monthly price against four-, eight-, ten- and twelve-week cycles, and the real cycle is usually disclosed somewhere below the price,” said Nora Bissett, pricing editor at GLP Watchdog. “A shipping cadence is not a billing cadence. We take the price from the checkout a customer actually goes through, carry required memberships and consultation fees into the figure, and date every capture.”
The FDA warning letter archive
The letters in the archive are public records already published by the Food and Drug Administration. GLP Watchdog’s contribution is organizing them by the operating company rather than by the brand name on the letterhead, so that a reader searching for a seller finds a letter written to its parent operator. A warning letter is disclosed as part of a seller’s entry. It is not treated as disqualifying on its own.
About GLP Watchdog
GLP Watchdog is an independent U.S. register of the companies selling GLP-1 medications online. It records what each seller charges per calendar month, which pharmacy dispenses the medication, and what federal regulators have said about the company behind the brand name. The site publishes rated entries for over 500 sellers, an archive of over 180 FDA warning letters, drug guides, state-by-state availability for all 50 states and the District of Columbia, and more than 340 research pages citing the published clinical evidence. Ratings are computed from six published measures, and every input traces to a document a reader can pull independently. It is an independent publisher. It is not a government agency, a regulator, or a licensing body, and it does not provide medical advice. More at https://glpwatchdog.org.
Media Contact:
Name: Ruth Calder
Company: GLP Watchdog
Email: ruth@glpwatchdog.org
Website: https://glpwatchdog.org